1
|
The Prognostic Utilities of Various Risk Factors for Laryngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Medicina (B Aires) 2023; 59:medicina59030497. [PMID: 36984498 PMCID: PMC10057849 DOI: 10.3390/medicina59030497] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 02/10/2023] [Accepted: 02/20/2023] [Indexed: 03/06/2023] Open
Abstract
Objective: To assess the prognostic utilities of various risk factors for laryngeal squamous cell carcinoma. Methods: Six databases were searched to January 2022. Hazard ratios for overall survival and disease-free survival were collected and study characteristics were recorded. The risk of bias was evaluated using the Newcastle–Ottawa scale. Results: Twenty-eight studies involving 32,128 patients were finally included. In terms of overall survival, older age, a history of alcohol consumption, a high Charlson comorbidity index score, a high TNM stage (III and IV), a high tumor stage (III and IV), nodal involvement, poor pathological differentiation, primary chemoradiotherapy and radiotherapy were associated with increased risks of death. In terms of disease-free survival, older age (≥60 years), TNM stages III and IV, tumor stages III and IV, supraglottic tumors, and nodal involvement all increased the risk of death. Conclusions: The TNM stage importantly predicts overall survival, and tumor location predicts the disease-free survival of patients with laryngeal squamous cell carcinoma. Of patients with risk factors, the Charlson comorbidity index usefully predicts overall survival.
Collapse
|
2
|
Huang Q, Guo Y, Shen Y, Hsueh CY, Tao L, Zhang M, Wu C, Gong H, Zhou L. Epidemiological, Clinical, and Oncological Outcomes of non-Alcohol Drinking and non-Smoking Laryngeal Squamous Cell Carcinoma Patients: A Distinct Entity. Technol Cancer Res Treat 2022; 21:15330338221133690. [PMID: 36259221 PMCID: PMC9583220 DOI: 10.1177/15330338221133690] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Purpose: To explore the discrepancy in clinicopathological and prognostic features between smoking and alcohol drinking (SA) and non-smoking and non-alcohol drinking (NSNA) patients with laryngeal squamous cell carcinoma (LSCC). Methods: This retrospective study including 1735 patients with LSCC was conducted from January 2005 to December 2010, which were categorized into 4 groups, NSNA group, smoking only group, alcohol-drinking only group, and SA group. We compared overall survival (OS) and disease-free survival (DFS) using the Kaplan-Meier method and indicated clinicopathological features by Cox proportional hazards regression models before and after propensity score matching (PSM). Results: A total of 415 patients (23.92%) were identified as NSNA. The SA group was predominantly patients ≤60 years old (46.63%) while the NSNA group was more older (58.07%). NSNA group was more likely to present at earlier disease stage and more female. No significant difference in OS (P = .685) and DFS (P = .976) was found between the 2 groups. In addition to age and recurrence and metastasis being common independent prognostic factors in terms of OS in both groups of patients, NSNA group also exhibited other factors, namely tumor area >3.7 cm2 and positive resection margin. For DFS, N + stage, tumor size >3.7 cm2, and positive resection margin were prognostic features specific to NSNA group. Conclusion: The outcome is similar in LSCC patients with and without SA. NSNA group shows a distinct profile from that found in SA group. Clinicopathological features from NSNA group should be considered for LSCC management.
Collapse
Affiliation(s)
- Qiang Huang
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
| | - Yang Guo
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
| | - Yujie Shen
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
| | - Chi-Yao Hsueh
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
| | - Lei Tao
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
| | - Ming Zhang
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
| | - Chunping Wu
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China
| | - Hongli Gong
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China,Hongli Gong, MD, Department of
Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031,
China.
| | - Liang Zhou
- Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China,Liang Zhou, MD, Department of
Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031,
China.
| |
Collapse
|
3
|
miR-206 Inhibits Laryngeal Carcinoma Cell Multiplication, Migration, and Invasion. JOURNAL OF HEALTHCARE ENGINEERING 2021; 2021:5614861. [PMID: 34868522 PMCID: PMC8642001 DOI: 10.1155/2021/5614861] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 10/22/2021] [Accepted: 10/28/2021] [Indexed: 12/29/2022]
Abstract
Laryngeal carcinoma (LC) is one of the common human cancer types. MicroRNAs (miRNAs) were reported to be the essential regulators in cancer diagnosis, treatment, and prognosis. It was reported that miR-206 expression was reduced in various neoplastic diseases. However, the role and functional mechanism of miR-206 in LC progression remain unclear. In this research, miR-206 was found to be associated with tumor-node-metastasis (TNM) staging. In addition, the area under the curve (AUC) of miR-206 was 0.902 for diagnosis of LC and 0.854 for differential diagnosis of stage I-II and stage III-IV patients. Low expression of miR-206 was associated with poor prognosis of LC patients. miR-206 expression was an independent factor affecting the prognosis of LC patients, as revealed by the Cox regression analysis. In vitro experiments demonstrated that miR-206 overexpression reduced cell multiplication, invasion, and migration and increased cell apoptosis in LC cells. Moreover, SOX9 was a target of miR-206, and miR-206 negatively regulated SOX9 expression. Collectively, miR-206 might be a promising biomarker with diagnostic and prognostic value for LC, and the miR-206/SOX9 axis might be a candidate target for LC therapy.
Collapse
|
4
|
Qi H, Chen W, Zhang C, Zheng X, Peng C, Zhao Q, Guo Y, Wu Y, Gao W, Wang B. Epidemiological Analysis of 1234 Cases of Laryngeal Cancer in Shanxi Province, China. Cancer Control 2021; 28:10732748211041236. [PMID: 34467770 PMCID: PMC8414613 DOI: 10.1177/10732748211041236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Background Laryngeal cancer is a common malignancy of the head and neck, especially in
northern China, including Shanxi province. This study intends to describe
the epidemiological characteristics of laryngeal cancer in Shanxi Province,
China, in order to support prevention and treatment efforts. Methods Retrospective analysis of the medical records of patients diagnosed with
laryngeal cancer in hospitals in Shanxi Province from 2008 to 2012. Results The average annual incidence rate of laryngeal cancer in Shanxi province from
2008 to 2012 was 0.70/105, the Chinese population standardized
incidence rate was 0.57/105 and the world population standardized
incidence rate was 0.60/105. The city with the highest incidence
of laryngeal cancer in Shanxi Province is Taiyuan, followed by Yangquan, and
the lowest incidence are Yuncheng and Jincheng. The cases included 723
farmers (58.6%), 338 workers (27.4%), 95 government cadres (7.7%), 35
unemployed individuals (2.8%), 30 teachers (2.4%) and 13 individuals with
other occupations (1.1%). The incidence of laryngeal cancer in rural areas
was 0.78/105, while urban areas was 0.60/105. Of 1006
patients with smoking and drinking status reported, there were 238 both
smoking and drinking (23.7%), 491 only smoking but not drinking (48.8%), 4
only drinking but not smoking (0.4%), 273 both not smoking and not drinking
(27.1%) (P<0.001), and there were 695 males smoking (95.3%), 34 females
smoking (4.7%) (P<0.001). Of 879 patients for whom the primary cancer
location was known, 406 cases (46.2%) were supraglottic and 428 cases
(48.7%) were glottic. Among 1009 patients with known pathological
classification, the vast majority had squamous cell carcinoma (992 cases,
98.3%). Conclusions To sum up, the incidence of laryngeal cancer in Shanxi Province exhibited a
relatively stable trend from 2008 to 2012, and the incidence is higher in
men than in women in all years. The high percentage of smokers in this study
underscores the importance of smoking as a risk factor for laryngeal cancer,
whereas rates of drinking did not appear to be linked. Incidence of
laryngeal cancer was higher in rural areas than in urban areas, a pattern
that differs from other regions of China and internationally.
Collapse
Affiliation(s)
- Hui Qi
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Nursing College, 74648Shanxi Medical University, Shanxi, P. R. China
| | - Wenjie Chen
- Department of Otolaryngology Head and Neck Surgery, Shanxi Bethune Hospital, Shanxi, P. R. China
| | - Chunming Zhang
- Department of Otolaryngology Head and Neck Surgery, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Research Center for Precision Medicine of Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Taiyuan, China
| | - Xiwang Zheng
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Research Center for Precision Medicine of Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Taiyuan, China
| | - Chen Peng
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Department of Head and Neck Surgery, 74648Shanxi Cancer Hospital of Shanxi Medical University, Shanxi, P. R. China
| | - Qinli Zhao
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Department of Otolaryngology Head and Neck Surgery, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Research Center for Precision Medicine of Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Taiyuan, China
| | - Yujia Guo
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Department of Otolaryngology Head and Neck Surgery, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Research Center for Precision Medicine of Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Taiyuan, China
| | - Yongyan Wu
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Department of Otolaryngology Head and Neck Surgery, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Research Center for Precision Medicine of Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Taiyuan, China.,Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Shanxi, P. R. China
| | - Wei Gao
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Department of Otolaryngology Head and Neck Surgery, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Research Center for Precision Medicine of Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Taiyuan, China.,Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Shanxi, P. R. China
| | - Binquan Wang
- Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Department of Otolaryngology Head and Neck Surgery, 74648First Hospital of Shanxi Medical University, Shanxi, P. R. China.,Research Center for Precision Medicine of Head and Neck Cancer, 74648First Hospital of Shanxi Medical University, Taiyuan, China
| |
Collapse
|
5
|
Role of Clinical-Demographic Data in Survival Rates of Advanced Laryngeal Cancer. ACTA ACUST UNITED AC 2021; 57:medicina57030267. [PMID: 33804150 PMCID: PMC8001944 DOI: 10.3390/medicina57030267] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Revised: 02/21/2021] [Accepted: 03/08/2021] [Indexed: 11/24/2022]
Abstract
Background and Objectives: Laryngeal cancer is one of the most common cancers in the upper aerodigestive tract, and tobacco and alcohol habits are the most relevant risk factors. The role of these risk factors in the incidence of laryngeal carcinomas is well known, yet only a few studies have been conducted on their role as risk factors of prognosis. The aim of the study was to assess the impact of clinical–demographic data on overall survival (OS), disease-free survival (DFS), and disease-specific survival (DSS) in patients with advanced-stage laryngeal cancer (Stage III–IV) who underwent total laryngectomy. Materials and Methods: This retrospective study was carried out on patients with Stage III–IV laryngeal squamous cell carcinoma treated with total laryngectomy between 2004 and 2014. For each patient, clinical and anamnestic data were collected and collated in a database, including alcohol and smoking habits. Results: Considering the variable age, family history, alcohol, grading, subsite, stage, pT stage, pN stage, and adjuvant therapy, no statistical significance was found for five-year OS. Smoking was the only variable that was statistically significant (p = 0.0043). A relevant difference was noted in the five-year DFS between pN-negative and pN-positive tumors (74.3% vs. 55.26%, respectively; p = 0.056), and a statistically significant difference was found between non- and ≤20 cigarettes/day smokers and heavy smokers (77.78% vs. 53.66%, respectively; p = 0.021). The five-year disease-specific survival rate was 68.83%, and a significant difference was detected for the smoking and pN stage variables. Heavy smokers (43.90% died vs. 16.67% of the non- and ≤20 cigarettes/day smokers; p = 0.0057) and pN-positive (42.1% died vs. 20.51% of the pN-negative patients; p = 0.042) patients had a worse prognosis. Conclusion: Smoking in our study was found to be an important independent risk factor for worse OS and DSS in patients with advanced laryngeal cancer.
Collapse
|